1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Rhythm Management Devices Market, China
3.1 Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2018-2033
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), by Segment, 2018-2033
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), by Segment, 2018-2033
3.1.3 Pacemakers Market, China, Revenue ($m), by Segment, 2018-2033
3.2 Cardiac Rhythm Management Devices Market, China, Volume (Units), 2018-2033
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), by Segment, 2018-2033
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), by Segment, 2018-2033
3.2.3 Pacemakers Market, China, Volume (Units), by Segment, 2018-2033
3.3 Cardiac Rhythm Management Devices Market, China, Average Price ($), 2018-2033
3.4 Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in China, Cardiac Rhythm Management Devices Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Biotronik SE & Co KG
4.3.1 Company Overview
4.4 Boston Scientific Corp
4.4.1 Company Overview
4.5 MicroPort Scientific Corp
4.5.1 Company Overview
5 Cardiac Rhythm Management Devices Market Pipeline Products6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Otsuka Holdings May Sell Stake in MicroPort Scientific
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jan 06, 2025: Concord Medical Announces Result of 2024 Annual General Meeting
7.1.2 Nov 13, 2024: Concord Medical Schedules 2024 Annual Meeting of Shareholders
7.2 Financial Announcements
7.2.1 Sep 27, 2024: Concord Medical Announces Results for H1 of 2024
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2018-2033
Table 3: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2018-2033
Table 4: Pacemakers Market, China, Revenue ($m), USD Constant, 2018-2033
Table 5: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2018-2033
Table 6: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2018-2033
Table 7: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2018-2033
Table 8: Pacemakers Market, China, Volume (Units), 2018-2033
Table 9: Cardiac Rhythm Management Devices Market, China, Average Price ($), 2018-2033
Table 10: Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), 2024
Table 11: Cardiac Rhythm Management Devices Market Pipeline Products
Table 12: Otsuka Holdings May Sell Stake in MicroPort Scientific
Table 13: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 4: Pacemakers Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 5: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2018-2033
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2018-2033
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2018-2033
Figure 8: Pacemakers Market, China, Volume (Units), 2018-2033
Figure 9: Cardiac Rhythm Management Devices Market, China, Company Share (%), 2024